Join BOPA
Back to news articles

Vision and Common Purpose for UK Pharmacy Professional Leadership – UKPPL Board and BOPA

By BOPA Executive Committee on 21st May 2025

BOPA is an Ex-Officio Member (Specialist Pharmacy Group) of the UKPPL Board with our Chair, Joseph Williams, representing BOPA members and all Cancer Pharmacy Professionals.  Through the Board’s work, closer collaboration between pharmacy professional leadership bodies and specialist pharmacy groups, supported by Independent Expert Members, we will enable and support pharmacists, pharmacy technicians and the wider pharmacy team to meet the opportunities and challenges ahead for the Pharmacy Profession.

For more information, please click on the links below:

Find out more on UKPPL and BOPA on our webinar HERE: [Free] UKPPL Board and BOPA – Collaborative Pharmacy Professional Leadership (12th February 2025) – BOPA

Independent UK Pharmacy Professional Leadership Advisory Board to strengthen collaboration | Join the Conversation

Vision and Common Purpose for UK Pharmacy Professional Leadership – BOPA – BOPA

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article